title: Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum.
abstract: Hepatocellular carcinoma (HCC) represents an important public health problem in Egypt where up to 90% of HCC cases are attributable to hepatitis C viral (HCV) infection. Serum alpha-fetoprotein is elevated in only approximately 60% of HCC patients. The development of effective markers for the detection of HCC could have an impact on cancer mortality and significant public health implications worldwide. The objective of our study was to assess six candidate markers for detection of HCC identified by mass spectrometric analysis of enriched serum. The study examined 78 HCC cases and 72 age- and gender-matched cancer-free controls recruited from the Egyptian population. Matrix-assisted laser desorption-ionization time-of-flight mass spectrometric analysis of enriched low-molecular weight fraction of serum was used for identification of the candidate markers. Our analyses show that all six candidate markers are associated with HCC after adjustment for important covariates including HCV and hepatitis B viral infections. The marker candidates are independently predictive of HCC with areas under the receiver operating characteristic (AuROC) curve ranging from 63-93%. A combination of the six markers improves prediction accuracy to 100% sensitivity, 91% specificity and 98% AuROC curve in an independent test set of 50 patients. Two of the candidate markers were identified by sequencing as fragments of complement C3 and C4. In conclusion, a set of six peptides distinguished with high prediction accuracy HCC from controls in an Egyptian population with a high rate of chronic HCV infection. Further evaluation of these marker candidates for the diagnosis of HCC is needed.
authors.affiliation: Georgetown University, Lombardi Comprehensive Cancer Center, 3970 Reservoir Road Northwest, Washington, DC 20057, USA. rg26@georgetown.edu
authors.forename: Radoslav
authors.initials: R
authors.lastname: Goldman
authors.forename: Habtom W
authors.initials: HW
authors.lastname: Ressom
authors.forename: Mohamed
authors.initials: M
authors.lastname: Abdel-Hamid
authors.forename: Lenka
authors.initials: L
authors.lastname: Goldman
authors.forename: Antai
authors.initials: A
authors.lastname: Wang
authors.forename: Rency S
authors.initials: RS
authors.lastname: Varghese
authors.forename: Yanming
authors.initials: Y
authors.lastname: An
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Loffredo
authors.forename: Steven K
authors.initials: SK
authors.lastname: Drake
authors.forename: Sohair A
authors.initials: SA
authors.lastname: Eissa
authors.forename: Iman
authors.initials: I
authors.lastname: Gouda
authors.forename: Sameera
authors.initials: S
authors.lastname: Ezzat
authors.forename: Francoise Seillier
authors.initials: FS
authors.lastname: Moiseiwitsch
mesh_terms: D000293:Adolescent; D014408:Biomarkers, Tumor / Q000097:blood*; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000175:diagnosis*; D004534:Egypt; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000175:diagnosis*; D008297:Male; D008970:Molecular Weight; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D000509:alpha-Fetoproteins / Q000032:analysis
chemical_list: D014408:Biomarkers, Tumor; D000509:alpha-Fetoproteins